LSTA · Lisata Therapeutics, Inc. · Proposed Sales
$1.64
-0.26 (-13.68%)
At close · Sep 10
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current business plan and existing capital resources, management has concluded that there is substantial doubt regarding our ability to continue as a going concern for a period of twelve months from the date of issuance of the accompanying consolidated financial statements.”View the 10-Q filed Aug 6, 2026
Market Cap
$14.78M
Shares
9.01M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.
Key facts
CIK
320017
CUSIP
128058302
13F (30d)
21 filings
21 filers
Visit website
Investor relations